Literature DB >> 3755463

Determination of circulating monomeric katacalcin and calcitonin: physiological studies in normal subjects.

W Woloszczuk, H Schuh, J Kovarik.   

Abstract

Katacalcin is a recently discovered peptide, contained within the calcitonin precursor. For the highly sensitive radioimmunological measurement of katacalcin and calcitonin we used extraction on C-18, thereby lowering the detection limits in serum to 0.8 pmol/l (katacalcin) and 0.7 pmol/l (calcitonin), and simultaneously improving the specificities of both assays for the monomeric forms of the peptides. Extraction recoveries were greater than 96% and greater than 95% for pure monoiodinated [125I]Tyr(0)-katacalcin and [125I]calcitonin, respectively; and 95-98% and 91-97% respectively for the corresponding unlabelled peptides. This method is sufficiently sensitive and specific for studies on the physiology of both peptides. Gel filtration of serum from a patient with medullary carcinoma of the thyroid showed that the majority of high molecular weight forms of katacalcin and calcitonin did not bind to C-18, and that the eluted material consisted to more than 90% of monomeric katacalcin and calcitonin. Basal levels (mean +/- SEM) of katacalcin were higher in men (3.0 +/- 0.6 pmol/l, age less than 40 years, and 1.8 +/- 0.4 pmol/l, age greater than 40 years) and younger women (2.1 +/- 0.4 pmol/l) than in older women (1.3 +/- 0.6 pmol/l; p less than 0.02). The respective values for calcitonin were 5.1 +/- 0.9 and 4.0 +/- 0.6 pmol/l for young and older men, and 2.3 +/- 0.4 and 2.8 +/- 0.8 pmol/l for young and older women, with a significant sex-related difference in both age groups. Basal serum levels of katacalcin and calcitonin were highly correlated (katacalcin = 0.66 calcitonin -0.12 pmol/l; p less than 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3755463     DOI: 10.1515/cclm.1986.24.7.451

Source DB:  PubMed          Journal:  J Clin Chem Clin Biochem        ISSN: 0340-076X


  1 in total

1.  Evaluation of sensitive PDN-21 (katacalcin) determination as tumor marker in medullary thyroid carcinoma.

Authors:  E Blind; F Raue; T Klaiber; A Zink; J Schroth; H Buhr; R Ziegler
Journal:  J Endocrinol Invest       Date:  1992-02       Impact factor: 4.256

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.